Pierre De Meyts belgian scientist
De Meyts, Pierre
VIAF ID: 272612542 (Personal)
Permalink: http://viaf.org/viaf/272612542
Preferred Forms
-
- 100 1 _ ‡a De Meyts, Pierre
- 100 1 _ ‡a De Meyts, Pierre
- 100 1 _ ‡a De Meyts, Pierre (sparse)
-
- 100 0 _ ‡a Pierre De Meyts ‡c belgian scientist
4xx's: Alternate Name Forms (3)
Works
Title | Sources |
---|---|
The A-chain of insulin contacts the insert domain of the insulin receptor. Photo-cross-linking and mutagenesis of a diabetes-related crevice | |
Activation of the insulin receptor by insulin and a synthetic peptide leads to divergent metabolic and mitogenic signaling and responses | |
Carbohydrate metabolism in women who used oral contraceptives containing levonorgestrel or desogestrel: a 6-month prospective study. | |
Cooperativity in ligand binding: a new graphic analysis | |
Crystal Structure of a"Nonfoldable"Insulin: IMPAIRED FOLDING EFFICIENCY DESPITE NATIVE ACTIVITY | |
DOK4/IRS-5 expression is altered in clear cell renal cell carcinoma | |
Down-regulation of cyclin G2 by insulin, IGF-I (insulin-like growth factor 1) and X10 (AspB10 insulin): role in mitogenesis | |
Drosophila Insulin-Like Peptides DILP2 and DILP5 Differentially Stimulate Cell Signaling and Glycogen Phosphorylase to Regulate Longevity. | |
Genetic engineering in mice: impact on insulin signalling and action. | |
Glycosylation of cell surface receptors: tunicamycin treatment decreases insulin and growth hormone binding to different levels in cultured lymphocytes | |
Growth failure in a child showing characteristics of Seckel syndrome: possible effects of IGF-I and endogenous IGFBP-3 | |
The growth hormone (GH)-binding protein cloned from human IM-9 lymphocytes modulates the down-regulation of GH receptors by 22- and 20-kilodalton human GH in IM-9 lymphocytes and the biological effects of the hormone in Nb2 lymphoma cells | |
Harmonic oscillator model of the insulin and IGF1 receptors' allosteric binding and activation | |
How insulin binds: the B-chain alpha-helix contacts the L1 beta-helix of the insulin receptor. | |
How ligand binds to the type 1 insulin-like growth factor receptor. | |
Human insulin prepared by recombinant DNA techniques and native human insulin interact identically with insulin receptors | |
IGF-I, IGF-II, and Insulin Stimulate Different Gene Expression Responses through Binding to the IGF-I Receptor | |
Immunological and metabolic responses of patients with history of antibody-induced beef insulin resistance to treatment with beef, pork, human, and sulfated beef insulin. | |
Impaired negative cooperativity of the semisynthetic analogues human [LeuB24]- and [LeuB25]-insulins | |
In Memoriam: Guy Dodson (1937–2012) | |
Inhibition of insulin receptor binding by dimethyl sulfoxide | |
Insight into the molecular basis for the kinetic differences between the two insulin receptor isoforms | |
Insulin and insulin-like growth factor-I receptor mediated differentiation of 3T3-F442A cells into adipocytes: effect of PI 3-kinase inhibition. | |
Insulin and related proteins | |
Insulin-dependent regulation of insulin receptor concentrations: a direct demonstration in cell culture. | |
Insulin interactions with its receptors: experimental evidence for negative cooperativity. | |
Insulin-like growth factor I (IGF-I) is a more potent regulator of gene expression than insulin in primary human myoblasts and myotubes | |
The insulin receptor: a prototype for dimeric, allosteric membrane receptors? | |
Insulin receptor-deficient cells as a new tool for dissecting complex interplay in insulin and insulin-like growth factors. | |
The Insulin Receptor in Vertebrates Is Functionally More Conserved during Evolution than Insulin Itself | |
Insulin receptor substrates-5 and -6 are poor substrates for the insulin receptor. | |
Mapping of the residues responsible for the negative cooperativity of the receptor-binding region of insulin | |
Mitogenic potential of insulin on lymphoma cells lacking IGF-1 receptor. | |
Molecular mechanisms of differential intracellular signaling from the insulin receptor | |
Mutation of arginine 86 to proline in the insulin receptor alpha subunit causes lack of transport of the receptor to the plasma membrane, loss of binding affinity and a constitutively activated tyrosine kinase in transfected cells | |
Negative cooperativity in H2 relaxin binding to a dimeric relaxin family peptide receptor 1 | |
News | |
p38 MAPK activation upregulates proinflammatory pathways in skeletal muscle cells from insulin-resistant type 2 diabetic patients | |
Pancreatic hormone receptors on islet cells | |
Pancreatic α-cell hyperplasia and hyperglucagonemia due to a glucagon receptor splice mutation | |
Preparation and expression of biologically active prolactin and growth hormone receptors and suppressor of cytokine signaling proteins 1, 2, 3, and 6 tagged with cyan and yellow fluorescent proteins | |
The receptor binding properties of the 20K variant of human growth hormone explain its discrepant insulin-like and growth promoting activities | |
Receptor oligomerization in family B1 of G-protein-coupled receptors: focus on BRET investigations and the link between GPCR oligomerization and binding cooperativity | |
Regulation of Receptor by Homologous Hormone Enhances Sensitivity and Broadens Scope of Radioreceptor Assay for Human Growth Hormone | |
Reversal of insulin-induced negative cooperativity by monoclonal antibodies that stabilize the slowly dissociating ("Ksuper") state of the insulin receptor. | |
Role of histone and transcription factor acetylation in diabetes pathogenesis | |
Separation of fast from slow anabolism by site-specific PEGylation of insulin-like growth factor I (IGF-I). | |
The severe short stature in two siblings with a heterozygous IGF1 mutation is not caused by a dominant negative effect of the putative truncated protein. | |
Sphingosine, an inhibitor of protein kinase C, suppresses the insulin-like effects of growth hormone in rat adipocytes. | |
Structural and Biological Properties of the Drosophila Insulin-like Peptide 5 Show Evolutionary Conservation | |
Structural basis for the poisonous activity of a predator's venom insulin | |
Structural basis of the aberrant receptor binding properties of hagfish and lamprey insulins. | |
Structural biology of insulin and IGF1 receptors: implications for drug design | |
Structure of growth hormone and its receptor: an unexpected stoichiometry | |
Structures of insect Imp-L2 suggest an alternative strategy for regulating the bioavailability of insulin-like hormones | |
SysBioMed report: advancing systems biology for medical applications. | |
Timing-dependence of insulin-receptor mitogenic versus metabolic signalling: a plausible model based on coincidence of hormone and effector binding. | |
Total Solid-Phase Synthesis of Biologically Active Drosophila Insulin-Like Peptide 2 (DILP2). | |
Viral insulin-like peptides activate human insulin and IGF-1 receptor signaling: A paradigm shift for host-microbe interactions. |